EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potent activity of prostaglandin J2 on prostanoid DP receptors

Kanaho Senoo, Keijo Fukushima, Hitomi Yamamoto, Ayaka Hamaguchi, Akiko Suganami, Harumi Takano, Mayu Yamashita, John W Regan, Yutaka Tamura, Hiromichi Fujino

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.108523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Kanaho Senoo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima Universi…. Hauptthemen laut MEDLINE: Prostaglandin D2, Receptors, Prostaglandin, Receptors, Immunologic. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostaglandin D2 (PGD2), an anti-inflammatory mediator, is acting through Gs-protein coupled D-type prostanoid (DP) receptors. DP receptors are not extensively distributed; in tissues, they are the least abundant among members of the prostanoid receptor family, whereas their primary ligand PGD2 is the main prostanoid in most tissues. PGD2 is dehydrated or isomerized to a number of metabolites enzymatically or nonenzymatically. To understand why many metabolites of PGD2 are produced via different pathways, regular cell-based experiments, Black/Leff operational model calculations, and in silico simulations were utilized. Here we show that, among the five metabolites of PGD2, prostaglandin J2 (PGJ2) was the most potent metabolite for DP receptors, particularly in the cAMP signaling pathway. This result was attributed to PGJ2 forming an extra and/or stronger hydrogen bond by more negatively charged carbonyl in the cyclopentene ring with DP receptors than PGD2. Therefore, when PGD2 is released into the blood, it would activate DP receptors, which are then continuously activated by PGJ2 to sustain the DP receptor/cAMP-mediated signaling pathway. Thus, the anti-inflammatory effects of PGD2 may be taken over/out competed and/or even enhanced by PGJ2. Here, PGJ2 was found to be a standout mediator of cAMP-mediated signaling pathway, which induces more potent and prolonged DP receptor activities as a biased ligand, possibly for resolving the inflammatory reaction. Moreover, since each metabolite showed different properties, these results provide insight into why many metabolites of PGD2 are produced and the miscellaneous physiological roles induced by the main prostanoid in most tissues through the least abundant DP receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostaglandin D2Receptors, ProstaglandinReceptors, ImmunologicHumansCyclic AMPSignal TransductionHEK293 CellsAnimals

Stichwörter der Autor:innen

DP prostanoid receptorsG-protein coupled receptorsPGD(2)PGJ(2)biased agonistcAMPoperational model calculationprostaglandinreceptor regulationβ-catenin

Substanzen

Prostaglandin D2Receptors, ProstaglandinCyclic AMPprostaglandin D2 receptorReceptors, Immunologicprostanoid D receptor 1, human

Autor:innen und Institutionen

  • Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Department of Bioinformatics, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona, USA.
  • Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan. Electronic address: hfujino@tokushima-u.ac.jp.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Senoo, K., Fukushima, K., Yamamoto, H., Hamaguchi, A., Suganami, A., Takano, H., Yamashita, M., Regan, J. W., Tamura, Y., & Fujino, H. (2025). Potent activity of prostaglandin J2 on prostanoid DP receptors. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108523

Vancouver

Senoo K, Fukushima K, Yamamoto H, Hamaguchi A, Suganami A, Takano H, et al. Potent activity of prostaglandin J2 on prostanoid DP receptors. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108523

BibTeX
@article{Senoo2025,
  author = {Senoo, Kanaho and Fukushima, Keijo and Yamamoto, Hitomi and Hamaguchi, Ayaka and Suganami, Akiko and Takano, Harumi and Yamashita, Mayu and Regan, John W and Tamura, Yutaka and Fujino, Hiromichi},
  title = {Potent activity of prostaglandin J2 on prostanoid DP receptors},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.108523}
}
Kostenlos starten →